Feb 18 (Reuters) - GeneDx Holdings Corp WGS.O:
GENEDX HOLDINGS CORP: FY 2025 REVENUE GUIDANCE OF $350M TO $360M, EXOME/GENOME VOLUME AND REVENUE GROWTH OF AT LEAST 30%
GENEDX HOLDINGS CORP - FOURTH QUARTER 2024 REVENUES GREW TO $95.3 MILLION
Source text: ID:nBwbXVKqqa
Further company coverage: WGS.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.